Concord Drugs (BOM:538965) Accounts Payable & Accrued Expense : ₹0.0 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Concord Drugs Accounts Payable & Accrued Expense?

Concord Drugs's quarterly accounts payable & accrued expense increased from Jun. 2023 (₹0.0 Mil) to Sep. 2023 (₹48.6 Mil) but then declined from Sep. 2023 (₹48.6 Mil) to Dec. 2023 (₹0.0 Mil).

Concord Drugs's annual accounts payable & accrued expense increased from Mar. 2021 (₹33.7 Mil) to Mar. 2022 (₹77.2 Mil) but then declined from Mar. 2022 (₹77.2 Mil) to Mar. 2023 (₹54.3 Mil).

Concord Drugs Accounts Payable & Accrued Expense Historical Data

The historical data trend for Concord Drugs's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Drugs Accounts Payable & Accrued Expense Chart

Concord Drugs Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

429.47

129.94

33.69

77.20

54.30

Concord Drugs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															-	54.30	-	48.64	-

Concord Drugs Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Concord Drugs (BOM:538965) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Concord Drugs Ltd (BOM:538965) » Definitions » Accounts Payable & Accrued Expense

Traded in Other Exchanges

N/A

Address

3-11-451, L B Nagar, Hayatnagar Mandal, Hyderabad, TG, IND, 500074

Website

https://www.concorddrugs.in

Concord Drugs Ltd is an India based pharmaceutical company. The principal activity of the company is to manufacture licensed drugs based on the formulations approved. Its product portfolio includes Pharmaceutical Ready to fill Pellets, MUPS ((Multiple Unit Pellets System); Tissue Bio Adhesive; Injectables (Small Volume Parenterals); Capsules; Liquid Orals (Syrups & Suspensions); Dry Syrups (Powder) and Hand Sanitizers. Geographically, it operates only in India.

Concord Drugs (BOM:538965) Headlines

No Headlines